Covid-19 trends, vaccination pace among major drivers for markets: Analysts

Equity markets this week will be guided by COVID-19 trends, pace of vaccination and global factors amid lack of any major domestic trigger, analysts said.

stocks, markets, funds, growth, investments
Press Trust of India New Delhi
2 min read Last Updated : Jun 06 2021 | 10:38 AM IST

Equity markets this week will be guided by COVID-19 trends, pace of vaccination and global factors amid lack of any major domestic trigger, analysts said.

"Among the key factors, participants will be closely eyeing monsoon updates. Besides, macroeconomic data i.e IIP is scheduled for June 11. With receding COVID cases, the market anticipates further easing by the states ahead," said Ajit Mishra, VP Research. Religare Broking.

On the earnings front, while most of the heavyweights have already announced their numbers, few prominent names like Bata India, GAIL, SAIL, BHEL and DLF will announce results this week, Mishra said.

Industrial production data is scheduled to be announced on Friday post market hours. Union Bank of India, Petronet LNG and NHPC would also announce their quarterly earnings this week.

"The market is expected to maintain its resilience on a short to medium-term basis due to declining COVID cases and global risk-on strategy. Manufacturing and Industrial production data for the month of April are the key economic data points to be released this week," Vinod Nair, Head of Research at Geojit Financial Services said.

During the last week, the 30-share BSE benchmark rallied 677.17 points or 1.31 per cent.

"Investors will continue to focus on trajectory of daily caseload and vaccination ramp up in the country in the near term," said Binod Modi, Head Strategy at Reliance Securities.

Nirali Shah, Head of Equity Research, Samco Securities said, "Indian markets could continue to mimic the movement across global commodities and equities."

Meanwhile, trend in Brent crude, rupee and foreign institutional investors would also continue to guide markets.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCoronavirus TestsMarkets

First Published: Jun 06 2021 | 10:35 AM IST

Next Story